You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

45 Results
Guidelines and Advice
Status: Current
ID: 4-16
Version: 3
May 2025
Guidelines and Advice
Status: Current
ID: GL 20-2
Version: 2
Apr 2025
Drug
Other Name(s): Aromasin®
Aug 2025
Drug
Other Name(s): Neupogen®, Grastofil®, Nivestym®, Nypozi®, Filra™
Sep 2025
Drug
Other Name(s): Efudex® Cream , IV generic brands available
Sep 2025
Drug
Other Name(s): Euflex®
Aug 2025
Drug
Other Name(s): Faslodex®
Aug 2025
Drug
Other Name(s): Afinitor®
Dec 2025
Drug
Other Name(s): Xtandi®
Aug 2025
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Intent: Curative
Dec 2025
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Intent: Curative
Dec 2025
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    exemestane
Aug 2025

Pages